Work

The CRISPR/Cas9 system targeting EGFR exon 17 abrogates NF-κB activation via epigenetic modulation of UBXN1 in EGFRwt/vIII glioma cells

Year: 2016

Type: article

Source: Cancer Letters

DOI: 10.1016/j.canlet.2016.12.011

Authors: Kai Huang, Chao Yang, Qi-xue Wang, Yan-sheng Li, Chuan Fang, Yan-li Tan, Jian-wei Wei, Yun-fei Wang, Xin Li, Jun-hu Zhou, Bing-cong Zhou, Kai-kai Yi, Kai-liang Zhang, Jie Li, Chun-sheng Kang

Institutions: Tianjin Medical University General Hospital, Tianjin Medical University, Affiliated Hospital of Hebei University, Hebei University, Shandong University, Qilu Hospital of Shandong University

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National High-tech Research and Development Program, National Key Research and Development Program of China

OpenAlex ID: W2563286019

FWCI: 2

Cites: 44

Cited by: 47

Related to: 10